18(th) GCC Closed Forum: Compliance with FDA Biomarkers Guidance, Novel ELN/LIMS Platforms, Sample Reconciliation, Emerging Technologies, Improvements in ELISpot, Post-extraction Sample Stability, LBA Singlicate, Regulatory Inspections, Chicken anti-Human IgG, Cross-validation Harmonization.

Karnik S, Zimmer J, Gutekunst M, Gorityala S, Goodman J, Jerks E, Litwin V, Tang X, Leskovar A, Tary-Lehmann M, Lowes S, Lavelle A, Yuan M, Liu A, O'Brien K, Dong K, Sales K, Reuschel S, Keyhani A, Johnson D, Odell M, Abdeen SJ, Hays A, Beyerlein D, Johnson M, Yu M, Cotton S, Joyce P, Fang WWT, Garofolo W, Nadarajah S, Spytko A, Dufield D, Rutherford L, Pankratz T, Xu A, Sikkema D, Hyer E, Iles T, Bonner E, Dimarco C, Hristopoulos G, Patterson K, Nash B, Bretton V, Rocha A, Satterwhite C, Yamashita J, McNally J, Fang X, Fan L

Open source

DOI: 10.1080/17576180.2026.2696193
Published: 2026 Jun-Jun
Container: Bioanalysis
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/17576180.2026.2696193,
  title = {18(th) GCC Closed Forum: Compliance with FDA Biomarkers Guidance, Novel ELN/LIMS Platforms, Sample Reconciliation, Emerging Technologies, Improvements in ELISpot, Post-extraction Sample Stability, LBA Singlicate, Regulatory Inspections, Chicken anti-Human IgG, Cross-validation Harmonization.},
  author = {Karnik S and Zimmer J and Gutekunst M and Gorityala S and Goodman J and Jerks E and Litwin V and Tang X and Leskovar A and Tary-Lehmann M and Lowes S and Lavelle A and Yuan M and Liu A and O'Brien K and Dong K and Sales K and Reuschel S and Keyhani A and Johnson D and Odell M and Abdeen SJ and Hays A and Beyerlein D and Johnson M and Yu M and Cotton S and Joyce P and Fang WWT and Garofolo W and Nadarajah S and Spytko A and Dufield D and Rutherford L and Pankratz T and Xu A and Sikkema D and Hyer E and Iles T and Bonner E and Dimarco C and Hristopoulos G and Patterson K and Nash B and Bretton V and Rocha A and Satterwhite C and Yamashita J and McNally J and Fang X and Fan L},
  year = {2026},
  journal = {Bioanalysis},
  doi = {10.1080/17576180.2026.2696193},
  url = {https://doi.org/10.1080/17576180.2026.2696193}
}

RIS

TY  - JOUR
TI  - 18(th) GCC Closed Forum: Compliance with FDA Biomarkers Guidance, Novel ELN/LIMS Platforms, Sample Reconciliation, Emerging Technologies, Improvements in ELISpot, Post-extraction Sample Stability, LBA Singlicate, Regulatory Inspections, Chicken anti-Human IgG, Cross-validation Harmonization.
AU  - Karnik S
AU  - Zimmer J
AU  - Gutekunst M
AU  - Gorityala S
AU  - Goodman J
AU  - Jerks E
AU  - Litwin V
AU  - Tang X
AU  - Leskovar A
AU  - Tary-Lehmann M
AU  - Lowes S
AU  - Lavelle A
AU  - Yuan M
AU  - Liu A
AU  - O'Brien K
AU  - Dong K
AU  - Sales K
AU  - Reuschel S
AU  - Keyhani A
AU  - Johnson D
AU  - Odell M
AU  - Abdeen SJ
AU  - Hays A
AU  - Beyerlein D
AU  - Johnson M
AU  - Yu M
AU  - Cotton S
AU  - Joyce P
AU  - Fang WWT
AU  - Garofolo W
AU  - Nadarajah S
AU  - Spytko A
AU  - Dufield D
AU  - Rutherford L
AU  - Pankratz T
AU  - Xu A
AU  - Sikkema D
AU  - Hyer E
AU  - Iles T
AU  - Bonner E
AU  - Dimarco C
AU  - Hristopoulos G
AU  - Patterson K
AU  - Nash B
AU  - Bretton V
AU  - Rocha A
AU  - Satterwhite C
AU  - Yamashita J
AU  - McNally J
AU  - Fang X
AU  - Fan L
PY  - 2026
JO  - Bioanalysis
DO  - 10.1080/17576180.2026.2696193
UR  - https://doi.org/10.1080/17576180.2026.2696193
ER  -

APA

S, K., J, Z., M, G., S, G., J, G., E, J., V, L., X, T., A, L., M, T., S, L., A, L., M, Y., A, L., K, O., K, D., K, S., S, R., A, K., D, J., M, O., SJ, A., A, H., D, B., M, J., M, Y., S, C., P, J., WWT, F., W, G., S, N., A, S., D, D., L, R., T, P., A, X., D, S., E, H., T, I., E, B., C, D., G, H., K, P., B, N., V, B., A, R., C, S., J, Y., J, M., X, F., & L, F. (2026). 18(th) GCC Closed Forum: Compliance with FDA Biomarkers Guidance, Novel ELN/LIMS Platforms, Sample Reconciliation, Emerging Technologies, Improvements in ELISpot, Post-extraction Sample Stability, LBA Singlicate, Regulatory Inspections, Chicken anti-Human IgG, Cross-validation Harmonization.. Bioanalysis. https://doi.org/10.1080/17576180.2026.2696193

Source records

pubmed · retrieved 2026-09-25T21:30:37.341Z